CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 277 enrolled
Drug / intervention
DFD01 Spray +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01967069
NCT01967069Phase 3Completed
CompareCT.gov

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

Primus Pharmaceuticals·interventional·Posted Oct 22, 2013·Updated Mar 7, 2024

In Brief

A Phase 3 clinical trial evaluating DFD01 Spray and Vehicle Spray for Psoriasis. Completed, enrolled 277 participants across 28 sites.

Detailed Summary

The objectives of this study are to compare the efficacy and safety of DFD01 Spray to Vehicle Spray for topical treatment of moderate plaque psoriasis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesUnited States
CollaboratorsProsoft Clinical

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 22, 2013
Enrollment StartNov 1, 2013
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.7 years ago

Interventions

DFD01 Spraydrug

Vehicle Spraydrug